MNKD
MANNKIND Licenses Technosphere Platform for Inhaled GLP-1 Weight Drug
MannKind gets an equity stake, royalties and a board seat at Rose Pharma in exchange for inhalation technology and development work on ROSE-010 through Phase 1b.
MNKD
Market-moving news on MannKind (NASDAQ: MNKD): filings, earnings, deals and other events, from REDFILED.